fail in Biological Technology
Navigation Links
fail in Biological Technology
Patients Fail to Take Fake Medicines Risk Seriously
DUBLIN, October 26 /PRNewswire/ -- - International Call for Patient Group Task Force to Fight Growing Fake Medicines Trade Major international research, including the views of bodies that represent more than 121,000 patients across Europe, was unveiled today in Dublin, Ireland - one of the w...'Significant Disconnect' Exists Between Understanding Cholesterol Monitoring Versus Implementing Changes to Lower Cholesterol Levels PARSIPPANY, N.J., Sept. 4, 2007 /PRNewswire/ -- A recent survey of U.S. adults with high cholesterol* shows that in spite of concerns about the serious heal...
Researchers Work in-vitro on MRSA, VRE and other multi-resistant organisms PRINCETON, N.J., May 2 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, today announced that the journal Skin & Aging, in its annual review of top wound car...
How name-dropping can make interviews fail
No matter that Chicago is continually duking it out with Los Angeles for second place in the roster of largest U.S. cities. As a practical matter, Chicago's business community is finite. In Milwaukee and throughout the Midwest, the small-world phenomenon holds even more true. It therefore foll...ADVENTRX Pharmaceuticals Announces Financing
... clinical investigators, expert data monitoring committees, contract laboratories and contract research organizations, may be substandard, or they may fail to perform as expected; the risk that ADVENTRX's significantly reduced workforce and leadership by officers who do not have substantial previous exper...Five Questions About Protopic (tacrolimus) Ointment
...ors called topical calcineurin (cal-SEE-nur-in) inhibitors (TCIs) can be effective treatments for patients with mild, moderate or severe eczema(3) who fail to respond adequately to first-line prescription treatments, such as topical corticosteroids, or when those treatments are not advisable. Applied to t...Insmed to Host Second Quarter 2009 Conference Call
...y from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the ...Neurocrine Biosciences Reports Second Quarter 2009 Results
...ifically, the risks and uncertainties the Company faces with respect to the Company's GnRH program include risk that the elagolix clinical trials will fail to demonstrate that elagolix is safe and effective; risk that elagolix will not proceed to later stage clinical trials; and risks associated with the ...Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
...rs, followed by a more careful secondary scan of only a few containers that fail the primary test) holds promise as a feasible solution for meeting the 100%...y radiographic portals as they enter an international port. Containers that fail will not be placed in stacks for outbound containers, but will be flagged i...Asia Debut for Money-Saving Pharma-Packaging Machines from Ireland
...packs that pass the test can be returned to the production line. Packs that fail the test can have the contents removed for repackaging using one of Sepha&r...s have no influence over the results of the BlisterScan test as the Pass or fail status of each pocket is shown on the screen, and can be printed out or sav...ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009
...clinical investigators, expert data monitoring committees, contract laboratories and contract research organizations, may be substandard, or they may fail to perform as expected; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities a...Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
...pply for or receive a grant for an additional phase II trial, the FDA may interpret the results of studies differently than us, product candidates may fail in the clinic or may not be successfully marketed or manufactured, competing products may be more successful, our continuing efforts to grow the busin...Spherix Announces Termination of Arla License Agreement
... from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may i...Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
... from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may i...Rules-Based Medicine, Inc. Launches DiscoveryMAP(TM) Service for Drug and Diagnostic Development
...rug development or diagnostic discovery project. "Despite the known benefits of biomarkers in drug development, many biomarker discovery efforts fail to contribute because the patterns do not reproduce on a clinically validated platform. The RBM approach is to discover new biomarker patterns on the......viral infection" stated Donald Kerrish, President and CEO of Three Rivers Pharmaceuticals. Approximately 50% of patients with chronic hepatitis C fail to respond to their initial course of PEG-IFN/RBV therapy. No standard has yet emerged for second-line therapy, since simply repeating the same treat...
Insmed CEO Resigns Due to Health Concerns
... materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, product candidates may fail in the clinic or may not be successfully marketed or manufactured, the FDA may interpret the results of studies differently than us, the release of cl...ADVENTRX Pharmaceuticals Announces Closing of Financing
...rs; the risk that the performance of third parties on whom ADVENTRX relies to conduct its studies or evaluate the data may be substandard, or they may fail to perform as expected; the risk that ADVENTRX's common stock will be delisted by the NYSE Amex (formerly, the American Stock Exchange); the risk that...'Designer molecules' being developed to fight disease
...n carrying out numerous functions in the human body. Over time each protein has evolved to optimise its function. Disease could result if any of these fail to perform efficiently." "By generating designer proteins in test tubes, we can produce molecules that have specific actions to control processes i...Mexico Premiere for Money-Saving Pharma Leak Testing Equipment
...e in the blister pack. It is a non-destructive, clean, dry process so any packs that pass the test can be returned to the production line. Packs that fail the test can have the contents removed for repackaging using one of Sepha’s deblistering machines. The alternative Methylene blue dye test by co...Lumbar Matrix(TM) Scan From SpineMatrix(R) Revolutionizes the Diagnosis of Low Back Pain
...tic resonance imaging (MRI) and computed tomography (CT) scans - take into account the anatomy of the back but not the physiology. These methods often fail to pinpoint the precise cause of pain for this reason. More than 85 percent of patients with low back pain are never given a specific diagnosis, lead...ADVENTRX Pharmaceuticals Announces Financing
...rs; the risk that the performance of third parties on whom ADVENTRX relies to conduct its studies or evaluate the data may be substandard, or they may fail to perform as expected; the risk that ADVENTRX's common stock will be delisted by the NYSE Amex (formerly, the American Stock Exchange); the risk that...Spherix Regains Full NASDAQ Compliance
... from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may i...Spherix to Exhibit at the BIO 2009 International Convention
... from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may i...Insmed Announces First Quarter 2009 Financial Results
...materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, [product candidates may fail in the clinic or may not be successfully marketed or manufactured, the FDA may interpret the results of studies differently than us, competing product...Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution
...e in the blister pack. It is a non-destructive, clean, dry process so any packs that pass the test can be returned to the production line. Packs that fail the test can have the contents removed for repackaging using one of Sepha’s deblistering machines. The alternative Methylene blue dye test by co...Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
...tavance, and cannot be certain that this product candidate will receive regulatory approval or be successfully commercialized; clinical trial data may fail to adequately support the safety and efficacy of Acetavance, or the prevalence or severity of adverse side effects may be greater than anticipated, wh...Neurocrine Biosciences Reports First Quarter 2009 Results
...ifically, the risks and uncertainties the Company faces with respect to the Company's GnRH program include risk that the elagolix clinical trials will fail to demonstrate that elagolix is safe and effective; risk that elagolix will not proceed to later stage clinical trials; risks associated with the Comp......the integration of these businesses has required, and will likely continue to require, significant resources and management attention; If we fail to comply with complex and evolving laws and regulations in the U.S. and internationally, we could suffer penalties, or be required to pay substan...
Spherix Recruiting New 'Independent' Director to Regain NASDAQ Compliance
... from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may i...Insmed to Host First Quarter 2009 Conference Call
...y from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the ...Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board
... from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may i...Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
...nties include, without limitation, risks that closing conditions under our agreement with Merck & Co., Inc. may not be met, product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the ...Spherix Announces 2008 Financial Results
... from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may i...The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
...ss Journal, February 25, 2009) Hopps said that these companies often see difficulty due to the need to specialize. "They develop drugs that might fail in clinical trials or the regulatory phase, and that's a lot of money gone toward something that won't show a return on the investment." &...WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
...investments and capital expenditures; pharmaceutical companies may not change their business models as expected or in a manner favorable to us; we may fail to capitalize on the opportunities presented; we may not maintain our preferred provider status with our clients; and may be unable to successfully ex...Publication of Shire plc's Annual Report 2008
... that impose duties on the parties involved or may fail to contain adequate conditions to protect the Grou...oducts; - require the recall of products that fail to meet regulatory requirements; and - ...on and results of operations. The Group may fail to obtain, maintain, enforce or defend the intelle...Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
...nties include, without limitation, risks that closing conditions under our agreement with Merck & Co., Inc. may not be met, product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the ......im or otherwise, may not be available within anticipated time frames or may fail to meet expectations, which could adversely affect Helix's anticipated timi...rrence and success of which cannot be assured; the risk that many new drugs fail in later studies and clinical trials; the risk of unexpected side effects; ...
...heir contents cannot be re-used whether they pass the test or not. A Pass / fail status for each pack is determined by pre-programmed individual test metho...ple size requirements. On the touch screen, PakScan indicates the Pass/ fail status for each individual sachet, instantly identifying quality assurance ...
Other TagscupcupcupregularlyanvilDVTOther Contentsholdingholdingholdingholdingholdingholdingholdingholdingbreathbreathbreathbreathbreathbreathbreathcriteriacriteriacriteriacriteriacriteriacriteriacriteriabeersshapingshapingshapingshapingbiomedicinecachexia
(Date:12/14/2009)... INDIANAPOLIS The most comprehensive study to date of ... regrow appendages may provide important clues to how similar ... at the School of Science at Indiana University-Purdue University ... the amputated limbs of axolotls, a type of salamander ... from any level of amputation, with the hope that ...
(Date:12/14/2009)... use as a defining feature of humans. That,s until examples ... birds and an array of other mammals. Now, a report ... a Cell Press publication, adds an octopus to the growing ... manages a behavioral trick that the researchers call stilt walking. ... coconut shell "bowls," makes its eight arms rigid, and raises ...
(Date:12/14/2009)... As good as laparoscopy is in preventing some of ... have drawbacks, including reduced blood flow and organ dysfunction. Laparoscopy ... small incisions. , By adding another ... area during laparoscopy, researchers at Duke University Medical Center have ... surgery. , The gas ethyl nitrite (ENO) helped to ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2Tool use in an invertebrate: The coconut-carrying octopus 2Gas improves blood flow and organ status during minimally invasive surgery 2Health and Wellness Partners Inc Says to America Feel the Surge 59568 1Health and Wellness Partners Inc Says to America Feel the Surge 59568 2Health and Wellness Partners Inc Says to America Feel the Surge 59568 3NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 1NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 2NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 3NeuroAIDS is Target of Federal Grant to Childrens Hospital 59564 4NxStage 28R 29 to Report Third Quarter 2009 Financial Results 5519 1NxStage 28R 29 to Report Third Quarter 2009 Financial Results 5519 2(Date:12/14/2009)... highly stigmatized, according to psychiatrists Charles F. Zorumski, ... these Washington University physicians have written a book ... Zorumski and Rubin, who have more than 50 ... patient families, say some of the problems related ... lack of understanding psychiatry and what psychiatrists can ...
(Date:12/14/2009)... rates for meth and smoking, but concerns about ... News) -- Fewer teenagers are using methamphetamine, but ... of prescription drugs remains high, U.S. health officials ... drugs, such as the hallucinogenic salvia leaf and ... treatment of attention-deficit hyperactivity disorder (ADHD), appear to ...
(Date:12/14/2009)... HealthCare at Home now provides in-home caregivers who have been ... home nursing, rehab therapy, caregiver, and hospice services to San ... ... Walnut Creek, CA (PRWEB) December 14, 2009 -- Professional HealthCare ... total home health care, including nursing, rehab, personal caregiver and ...
(Date:12/14/2009)... Hospital records show consistent rate of lacerations, accidental ... ,, BOSTON, Dec. 14 A new ... Medicine has found that holiday decorations, particularly glass ... consider during the season. A review of records ... five ornament-related injuries per year, more than half ...
(Date:12/14/2009)... Calif., Dec. 14 Anthem Blue ... Care Services intends to award Anthem the Tri-County Commercial ... the Fresno, Kings and Madera Counties. This award is ... in the country this year. ,, "The award of ... to continue to deliver on the promise made to ...
Breaking Medicine News(10 mins):Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 3Health News:Anthem Blue Cross Wins Third Largest Medicaid Managed Care Contract Renewal in the Country 2[0] Book demystifies psychiatry for the general public[0] Marijuana Use No Longer Dropping Among U.S. Teens[0] Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association [0] Parents: Be Mindful of Hazardous Holiday Ornaments[0] Anthem Blue Cross Wins Third Largest Medicaid Managed Care Contract Renewal in the Country
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |